Help with addiction starts with one call.

877-922-8999
Person Person Person

Thousands of people helped nationwide.

Luminosity Bakari Program

Open Now
Contact Information
157 Main Street, Brockton, MA, Massachusetts 02301
0.000
Detailed Information

Luminosity Bakari Program – Comprehensive Outpatient Addiction Treatment

Located at 157 Main Street in Brockton, Massachusetts, the Luminosity Bakari Program provides specialized, trauma-informed outpatient treatment for substance use disorders and co-occurring mental health conditions. The center is dedicated to offering personalized, compassionate care that addresses both addiction and underlying mental health issues simultaneously, leading to more comprehensive healing.

Treatment Philosophy and Focus

The core philosophy of the Luminosity Bakari Program centers on addressing the complex interplay between substance use and mental health. Recognizing that a majority of individuals with addiction also struggle with mental health disorders, their approach integrates care for both conditions. Treatment plans are highly personalized to meet the unique needs of each individual.

Key Services and Modalities

Luminosity Bakari Program employs a variety of evidence-based therapeutic methods to support recovery. These treatments are delivered through an outpatient level of care, allowing clients to maintain their work, family, and educational commitments while receiving intensive support.

  • Individual Counseling
  • Group Counseling
  • Family Counseling and Couples Counseling
  • Cognitive Behavioral Therapy (CBT)
  • Motivational Interviewing
  • Brief Intervention
  • Anger Management
  • Relapse Prevention

Specialized Care for Opioid Use Disorders

The facility has a strong focus on treating opioid addictions, including those involving heroin, fentanyl, and prescription painkillers. This specialized care often incorporates Medication-Assisted Treatment (MAT). The program utilizes FDA-approved medications such as buprenorphine and naltrexone as part of a holistic treatment strategy that combines medication with counseling and behavioral therapies.

Accreditation and Reputation

Luminosity Bakari Program holds accreditations from reputable bodies, including the State Department of Health and The Joint Commission, ensuring that the facility meets rigorous standards for quality and effective treatment delivery. The center has received positive feedback from users, reflected in its high Trustscore rating of 4.48/5.

Frequently Asked Questions (FAQs)

What is the primary level of care offered?

The primary level of care offered by the Luminosity Bakari Program is Outpatient treatment.

Do they treat mental health conditions?

Yes, the center treats co-occurring mental health conditions alongside substance use disorders, offering integrated care for both.

Does Luminosity Bakari Program accept insurance?

While the center accepts Medicaid and Medicare, it is best to contact the facility directly to verify your specific insurance coverage.

Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Type of Care
Substance use treatment
Detoxification
Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting
Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment, Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification
Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Lofexidine or Clonidine detoxification
Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Buprenorphine with naloxone
Buprenorphine without naloxone
Naltrexone (oral)
Naltrexone (extended-release, injectable)
Lofexidine
Clonidine
Medication for mental disorders
Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management
Brief intervention
Cognitive behavioral therapy
Motivational interviewing
Relapse prevention
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
Facility Operation
Private non-profit organization
License/Certification/Accreditation
State substance use treatment agency
State department of health
The Joint Commission
Find Help (877) 922-8999